INNOVATIVE IMPLANTABLE GLUCOSE BIOSENSOR

Information

  • Research Project
  • 2870324
  • ApplicationId
    2870324
  • Core Project Number
    R43DK055958
  • Full Project Number
    1R43DK055958-01
  • Serial Number
    55958
  • FOA Number
  • Sub Project Id
  • Project Start Date
    5/1/1999 - 25 years ago
  • Project End Date
    4/30/2000 - 24 years ago
  • Program Officer Name
    HARMON, JOAN T.
  • Budget Start Date
    5/1/1999 - 25 years ago
  • Budget End Date
    4/30/2000 - 24 years ago
  • Fiscal Year
    1999
  • Support Year
    1
  • Suffix
  • Award Notice Date
    4/19/1999 - 25 years ago
Organizations

INNOVATIVE IMPLANTABLE GLUCOSE BIOSENSOR

This proposal describes the design and testing of an innovative implantable glucose sensor using pH-sensitive hydrogels and pressure sensing technology. This system is based on pressure transducers and/or piezoelectric transducers in combination with pH-sensitive hydrogels containing glucose oxidase (GOD). The hydrogels swell in response to decreases in pH due to the presence of pH-sensitive pendant groups in the gel. Decreases in pH within the gel occur in response to increases in the surrounding glucose concentration, because gluconic acid is generated by GOD when glucose and oxygen are present. The pH-sensitive hydrogels are swollen by an amount which is proportional to glucose concentration. The swollen hydrogels will give an elevated pressure within the limited chamber which encloses the gel, which can be detected using miniature pressure sensors of well-tested design. Thus glucose concentrations can be continuously monitored using the combination technologies of hydrogels and pressure sensors. The optimal conditions of pH-sensitive gels such as cross-link density, number and type of pendant groups, GOD level, catalase level, gel thickness, etc. will be determined by in vitro measurements of sensor response time, linearity, and oxygen sensitivity, and used to establish the technical merit and feasibility of pressure-based glucose monitoring in Phase I. PROPOSED COMMERCIAL APPLICATIONS: Implantable glucose biosensors developed herein could be commercially applied as clinical sensors.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R43
  • Administering IC
    DK
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
  • Organization Name
    M-BIOTECH, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    SANDY
  • Organization State
    UT
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    84070
  • Organization District
    UNITED STATES